Hostname: page-component-76fb5796d-45l2p Total loading time: 0 Render date: 2024-04-26T19:13:01.326Z Has data issue: false hasContentIssue false

Examining the need for eye protection for coronavirus disease 2019 (COVID-19) prevention in the community

Published online by Cambridge University Press:  24 June 2020

Alexandre R. Marra
Affiliation:
Center for Access & Delivery Research and Evaluation (CADRE), Iowa City VA Health Care System, Iowa City, Iowa, United States Department of Internal Medicine, University of Iowa Hospital & Clinics, Iowa City, Iowa, United States Albert Einstein Jewish Institute for Education and Research, Hospital Israelita Albert Einstein, São Paulo, Brazil
Michael B. Edmond
Affiliation:
Department of Internal Medicine, University of Iowa Hospital & Clinics, Iowa City, Iowa, United States
Saskia V. Popescu
Affiliation:
George Mason University, Fairfax, Virginia, United States
Eli N. Perencevich*
Affiliation:
Center for Access & Delivery Research and Evaluation (CADRE), Iowa City VA Health Care System, Iowa City, Iowa, United States Department of Internal Medicine, University of Iowa Hospital & Clinics, Iowa City, Iowa, United States
*
Author for correspondence: Eli N. Perencevich, E-mail: eli-perencevich@uiowa.edu
Rights & Permissions [Opens in a new window]

Abstract

Type
Letter to the Editor
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.

To the Editor—As the world reopens after extreme social distancing designed to flatten the curve and protect hospitals, it appears that even countries that had controlled coronavirus disease 2019 (COVID-19) with widespread testing and contact tracing, such as South Korea and Singapore, are seeing increased case counts. One proposed method for reducing transmission as society reopens is requiring the public to wear face coverings, including cotton face masks or face shields.Reference Perencevich, Diekema and Edmond1 An important factor that distinguishes face shields from masks is eye protection. Yet the importance of eye protection in the prevention of COVID-19 and other coronaviruses is underappreciated, which has led to public health authorities recommending cotton face masks over potentially more protective alternatives, such as face shields.

The mucous membranes of healthcare workers (HCWs), including the conjunctiva, may be exposed to respiratory droplets from the patient.Reference Khunti, Greenhalgh and Chan2 The importance of eye protection during care of patients with novel coronaviruses was recognized in 2003 during the severe acute respiratory syndrome coronavirus (SARS-CoV-1) outbreaks and subsequent Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks.Reference Chou, Dana, Buckley, Selph, Fu and Totten3 For example, during SARS, the lack of eye protection when transferring a patient may have been the primary risk factor for one of the first doctors infected.Reference Fisher, Chew, Lim and Tambyah4

It has been increasingly recognized that severe acute respiratory coronavirus virus 2 (SARS-CoV-2) can be transmitted from infected individuals when they are asymptomatic or presymptomatic.Reference Chou, Dana, Buckley, Selph, Fu and Totten3,Reference Sun, Wang, Liu and Liu5 Thus, to prevent transmission in the community, personal protective equipment (PPE) must be worn at all times in addition to other containment measures such as 2 m (6 feet) distancing and avoiding large gatherings. Both droplet and contact transmission routes have been implicated in the spread of SARS-CoV-2.Reference Perencevich, Diekema and Edmond1,Reference Chou, Dana, Buckley, Selph, Fu and Totten3 PPE has 2 potential benefits when worn in the community: (1) PPE can provide source control by containing the respiratory droplets generated through coughs, sneezes or during speech and (2) PPE can act as a barrier preventing respiratory droplets from landing on facial mucosal membranes or other parts of the face. Additionally, PPE can prevent contact transmission by preventing contaminated hands from reaching the mucosal membranes of the mouth, nose and eyes.

Eye protection might provide additional benefits. A detailed investigation of risk factors for HCW acquisition of SARS, including multivariate generalized estimating equation logistic regression models, identified unprotected eye contact with body fluids as an independent risk factor for infection (odds ratio [OR], 7.34; P = .001).Reference Raboud, Shigayeva and McGeer6 However, in a survey of 8 of the 9 US healthcare facilities in which SARS-CoV-1–infected patients were evaluated, 70% of HCWs reported some exposure to patients without wearing some level of eye protection and none acquired infection.Reference Park, Peck and Kuehnert7

Although conjunctivitis has been described in a few patients with COVID-19 and other coronavirus syndromes,Reference Sun, Wang, Liu and Liu5 emerging evidence supports that coronavirus can enter the host via the conjunctival route.Reference Siedlecki, Brantl and Schworm8 Conjunctiva may be a potential portal for infectionReference Chen, Liu and Zhang9 because it is directly exposed to extraocular pathogens, and the mucosa of the ocular surface and upper respiratory tract are connected by the nasolacrimal duct and have been shown to share the same entry receptors for some respiratory viruses,Reference Sun, Wang, Liu and Liu5 including angiotensin-converting enzyme 2 (ACE2) for SARS-CoV-1 and SARS-CoV-2.Reference Khunti, Greenhalgh and Chan2,Reference Sun, Wang, Liu and Liu5 In addition, SARS-CoV-2 was detectable in several nasolacrimal system–associated tissues, including the conjunctiva, lacrimal gland, nasal cavity, and throat, thus validating the anatomical bridge between ocular mucosa and the respiratory tract.Reference Siedlecki, Brantl and Schworm8 Finally, macaques were susceptable to SARS-CoV-2 infection via the conjunctival route and progressed to lung infections suggesting the biological importance of eye infection.Reference Deng, Bao and Gao10

Given that SARS-CoV-2 can be transmitted by fomites and droplets that contact the mucous membranes of the mouth and nose, as well as the eyes, it appears that until proven otherwise, HCWs and at-risk citizens in the community should use barriers to protect their entire face including their eyes. Current public health guidance recommends cotton face masks, but given the potential role of the conjunctival route, face shields that provide barrier protection for the entire face might be the superior option. Further research in this area is critically needed.

Acknowledgments

Financial support

All authors report no source of funding or support.

Conflicts of interest

All authors report no conflicts of interest relevant to this article.

References

Perencevich, EN, Diekema, DJ, Edmond, MB. Moving personal protective equipment into the community: face shields and containment of COVID-19. JAMA 2020;323:22522253.CrossRefGoogle ScholarPubMed
Khunti, K, Greenhalgh, T, Chan, XH, et al. What is the efficacy of eye protection equipment compared to no eye protection equipment in preventing transmission of COVID-19-type respiratory illness in primary and community care? The Centre for Evidence-Based Medicine website. https://www.cebm.net/covid-19/what-is-the-efficacy-of-eye-protection-equipment-compared-to-no-eye-protection-equipment-in-preventing-transmission-of-covid-19-type-respiratory-illnesses-in-primary-and-community-care/. Accessed May 28, 2020.Google Scholar
Chou, R, Dana, T, Buckley, DI, Selph, S, Fu, R, Totten, AM. Epidemiology of and risk factors for coronavirus infection in healthcare workers. Ann Intern Med 2020 May 5 [Epub ahead of print]. doi: 10.7326/M20-1632.CrossRefGoogle Scholar
Fisher, DA, Chew, MN, Lim, YT, Tambyah, PA. Preventing local transmission of SARS: lessons from Singapore. Med J Aust 2003;178:555558.CrossRefGoogle ScholarPubMed
Sun, CB, Wang, YY, Liu, GH, Liu, Z. Role of the eye in transmitting human coronavirus: what we know and what we do not know. Front Public Health 2020;8:155.CrossRefGoogle Scholar
Raboud, J, Shigayeva, A, McGeer, A, et al. Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada. PLoS One 2010;5(5):e10717.CrossRefGoogle ScholarPubMed
Park, BJ, Peck, AJ, Kuehnert, MJ, et al. Lack of SARS transmission among healthcare workers, United States. Emerg Infect Dis 2004;10:244248.CrossRefGoogle ScholarPubMed
Siedlecki, J, Brantl, V, Schworm, B, et al. COVID-19: ophthalmological aspects of the SARS-CoV 2 global pandemic. Klin Monbl Augenheilkd 2020;237:675680.Google ScholarPubMed
Chen, L, Liu, M, Zhang, Z, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol 2020 Apr 7 [Epub ahead of print]. doi: 10.1136/bjophthalmol-2020-316304.CrossRefGoogle Scholar
Deng, W, Bao, L, Gao, H, et al. Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in Rhesus macaques. bioRxiv; 2020. doi: 10.1101/2020.03.13.990036.CrossRefGoogle Scholar